European Journal of Pharmaceutical Sciences
Elsevier BV · NL · ISSN 09280987
What the numbers say
Publication volume tightened while average citedness edged up.
Output shrank while citation impact rose. If you prioritise visibility per paper, this trend is relevant to your choice. Field-weighted citation impact moved from 1.89 to 1.91. Expect modestly higher average attention for articles here than in many places. RNA Interference and Gene Delivery rose from 2.0% to 5.4% of what the journal runs. Consider submitting RNA interference work when seeking topical fit. Gold open access accounts for 100.0%. Be prepared for article processing charges typical of full open access venues.
Citation metrics
Based on the Scopus and OpenAlex citation graphs. We do not provide Clarivate’s JCR Impact Factor.
Output and citation impact
Whether citation performance keeps up as output grows.
Topic shift
Share in the last 24 months (2024-09 – 2026-08) versus the previous 24 (2022-09 – 2024-08).
- RNA Interference and Gene Delivery2.0%→5.4%+3.4%pPrevNow
- Protein purification and stability2.4%→5.7%+3.3%pPrevNow
- Lipid Membrane Structure and Behavior0.0%→3.2%+3.2%pPrevNow
- Crystallization and Solubility Studies0.0%→2.1%+2.1%pPrevNow
- Ocular Surface and Contact Lens0.0%→2.1%+2.1%pPrevNow
- Drug Solubulity and Delivery Systems19.4%→15.7%−3.7%pPrevNow
- Antibiotics Pharmacokinetics and Efficacy2.8%→0.0%−2.8%pPrevNow
- Diabetes Treatment and Management2.8%→0.0%−2.8%pPrevNow
- Pharmacological Effects and Toxicity Studies2.4%→0.0%−2.4%pPrevNow
- Extracellular vesicles in disease2.4%→0.0%−2.4%pPrevNow
Terms appearing more often
Wording in recent paper titles that stands out against the journal's own baseline.
Author countries
Last 24 months (2024-09 – 2026-08) against the previous 24 (2022-09 – 2024-08).
- CN41.3%→23.0%−18.3%pPrevNow
- DE12.0%→21.1%+9.1%pPrevNow
- US15.1%→15.4%+0.3%pPrevNow
- FI7.2%→9.5%+2.3%pPrevNow
- GB5.5%→9.1%+3.5%pPrevNow
- HU0.0%→7.8%+7.8%pPrevNow
Top 5 institutions
Top 5 institutions publishing in this journal, 2018 – 2026.
Recently published
20The 20 most recent papers — not the full list.
Most cited
20Top 20 most cited, 2018 – 2026.
Check your draft against this journal
Start free with Nubint AI — citation checks and a peer-review simulation.
Data as of 2026-09-05